Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASF-1096 in Discoid Lupus Erythematosus
NCT00625157Phase 2Completed
- Sponsor
- Astion Pharma
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ASF-1096 in discoid lupus erythematosus (DLE) (2 arms), sponsored by Astion Pharma. Status: completed.
02
Drugs
ASF-1096
03
Conditions
discoid lupus erythematosus (DLE)
Beyond the preview
Go deeper on NCT00625157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00625157.